EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
S. Geroulanos
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kriaras, I.
Right arrow Articles by Geroulanos, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kriaras, I.
Right arrow Articles by Geroulanos, S.

Eur J Cardiothorac Surg 2000;18:440-446
© 2000 Elsevier Science NL


Review article

Evolution of antimicrobial prophylaxis in cardiovascular surgery

I. Kriarasa, A. Michalopoulosa, M. Turinab, S. Geroulanosa

a Department of Surgical Intensive Care, Onassis Cardiac Surgery Center, 356 Sygrou Avenue, 17674 Athens, Greece
b Department of Cardiovascular Surgery, University Hospital, Zurich, Switzerland

Received 29 December 1999; received in revised form 20 April 2000; accepted 26 April 2000.

Corresponding author. Tel.: +30-1-949-3335; fax: +30-1-949-3333

Objective: To examine the optimal duration of antibiotic prophylaxis in major cardiovascular surgery. Methods: In the past 15 years, four prospective randomized, controlled studies, conducted by the same group of authors, compared seven prophylactic antimicrobial regimens in 2970 patients undergoing major cardiovascular surgery. In 1980/81, a 4-day cefazolin (CFZ) prophylaxis was compared with a 2-day cefuroxime (CFX) administration (n=566). In 1982/83, a 2-day CFX prophylaxis was compared with a two shot ceftriaxone (CRO) prophylaxis (n=512). In 1984/87, a 1-day CFZ prophylaxis was compared with a single shot prophylaxis of CRO (n=883). In 1994/1995, a 4 day combination of amoxicillin (AM) and netilmicin (NET) prophylaxis was compared with a single shot prophylaxis of CFX (n=1009). Results: Total infection rate varied between 4.5 and 5.7%, despite different antimicrobial regimen used and their varying duration. Wound infection rate was 1.1% (range 0.4–2.5%), sepsis rate was 0.8% (range 0.4–1.6%), pneumonia rate 2% (0.7–2.9%), urinary tract infection rate 0.4% (range 0–1.4%), and central venous catheter-related infection rate was 0.4% (0–1%). The 30-day mortality rate was 1.3% (range 0.4–2%). All these differences were not statistically significant. Conclusions: A low infection rate (range 4.5–5.7%) occurred despite changes in duration of various prophylactic antibiotic regimen with cephalosporins of first, second or third generation. As a single shot prophylaxis could nowadays successfully be used in cardiovascular surgery, no postoperative antibiotics should be used, unless an intraoperative or a postoperative infection is documented or in presence of major perioperative complications.

Key Words: Cardiovascular surgery • Antibiotic prophylaxis • Cefazolin • Cefuroxime • Ceftriaxone • Amoxicillin • Netilmicin




This article has been cited by other articles:


Home page
JBJSHome page
J. Meehan, A. A. Jamali, and H. Nguyen
Prophylactic Antibiotics in Hip and Knee Arthroplasty
J. Bone Joint Surg. Am., October 1, 2009; 91(10): 2480 - 2490.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. Kanter, N. R. Connelly, and J. Fitzgerald
A System and Process Redesign to Improve Perioperative Antibiotic Administration
Anesth. Analg., December 1, 2006; 103(6): 1517 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. H. Edwards, R. M. Engelman, P. Houck, D. M. Shahian, and C. R. Bridges
The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration
Ann. Thorac. Surg., January 1, 2006; 81(1): 397 - 404.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.